Literature DB >> 12419616

The fundamental contribution of phages to GAS evolution, genome diversification and strain emergence.

David J Banks1, Stephen B Beres, James M Musser.   

Abstract

The human bacterial pathogen group A Streptococcus (GAS) causes many different diseases including pharyngitis, tonsillitis, impetigo, scarlet fever, streptococcal toxic shock syndrome, necrotizing fasciitis and myositis, and the post-infection sequelae glomerulonephritis and rheumatic fever. The frequency and severity of GAS infections increased in the 1980s and 1990s, but the cause of this increase is unknown. Recently, genome sequencing of serotype M1, M3 and M18 strains revealed many new proven or putative virulence factors that are encoded by phages or phage-like elements. Importantly, these genetic elements account for an unexpectedly large proportion of the difference in gene content between the three strains. These new genome-sequencing studies have provided evidence that temporally and geographically distinct epidemics, and the complex array of GAS clinical presentations, might be related in part to the acquisition or evolution of phage-encoded virulence factors. We anticipate that new phage-encoded virulence factors will be identified by sequencing the genomes of additional GAS strains, including organisms non-randomly associated with particular clinical syndromes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419616     DOI: 10.1016/s0966-842x(02)02461-7

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  80 in total

1.  Integration and distribution of Lactobacillus johnsonii prophages.

Authors:  Marco Ventura; Carlos Canchaya; David Pridmore; Bernard Berger; Harald Brüssow
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

Review 2.  Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion.

Authors:  Harald Brüssow; Carlos Canchaya; Wolf-Dietrich Hardt
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

3.  Growth phase-dependent modulation of Rgg binding specificity in Streptococcus pyogenes.

Authors:  Srivishnupriya Anbalagan; Alexander Dmitriev; W Michael McShan; Paul M Dunman; Michael S Chaussee
Journal:  J Bacteriol       Date:  2012-05-25       Impact factor: 3.490

4.  Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes.

Authors:  Ramy K Aziz; Robert A Edwards; William W Taylor; Donald E Low; Allison McGeer; Malak Kotb
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

5.  Severe skin and soft tissue infections and associated critical illness.

Authors:  Donald C Vinh; John M Embil
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

6.  Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements.

Authors:  Francisco J M Mojica; César Díez-Villaseñor; Jesús García-Martínez; Elena Soria
Journal:  J Mol Evol       Date:  2005-02       Impact factor: 2.395

7.  Phage 3396 from a Streptococcus dysgalactiae subsp. equisimilis pathovar may have its origins in streptococcus pyogenes.

Authors:  Mark R Davies; David J McMillan; Gary H Van Domselaar; Malcolm K Jones; Kadaba S Sriprakash
Journal:  J Bacteriol       Date:  2007-01-26       Impact factor: 3.490

Review 8.  Impact of CRISPR immunity on the emergence and virulence of bacterial pathogens.

Authors:  Asma Hatoum-Aslan; Luciano A Marraffini
Journal:  Curr Opin Microbiol       Date:  2013-12-29       Impact factor: 7.934

9.  Phage Therapy - Everything Old is New Again.

Authors:  Andrew M Kropinski
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

10.  Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes.

Authors:  Jovanka M Voyich; Daniel E Sturdevant; Kevin R Braughton; Scott D Kobayashi; Benfang Lei; Kimmo Virtaneva; David W Dorward; James M Musser; Frank R DeLeo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.